Skip to main content
. 2022 Jun 23;149(5):1811–1823. doi: 10.1007/s00432-022-04103-0

Table 1.

Follow-up time for the detection of lung tumors in patients with ESCC

References Total LSPTs, n History of LC, n (%) Synchronous LSPTs, n (%) Metachronous LSPTs, n (%) Time from LC in history to ESCC Time to detection of metachronous LSPTs
Ven et al. (2020) 219 123 (56.2) 96 (43.8) Median 3.2 year (IQR 1.9–4.5)
Yoshida et al. (2020) 22 4 (18.2) 2 (9.1) 16 (72.7) NR NR
Yamaguchi et al. (2018) 5 5 (100.0) NR
Otowa et al. (2016) 6 4 (66.7) 2 (33.3) 0 NR
Lee et al. (2013) 18 1 (5.6) 9 (50.0) 8 (44.4) NR NR
Chuang et al. (2008) 338 226 (66.9) 30 (26.8) 82 (73.2)

 < 12 months n = 62

1–4 year n = 83

5–9 year n = 48

 ≥ 10 year n = 33

6–11 months n = 6

1–4 year n = 43

 ≥ 5 year n = 33

Motoyama et al. (2003) 9 9 (100.0) Reported for 5 patients: 12, 14, 20, 23, 43 and 112 months
Kokawa et al. (2001) 13 2 (15.4) 4 (30.8) 7 (53.8) NR Mean 23 months (sd 10.4)
Kumagai et al. (2001) 5 1 (20.0) 3 (60.0) 1 (20.0) NR NR
Ribeiro Júnior et al. (1999) 2 1 (50.0) 0 1 (50.0) 2 years 6 year
Poon et al. (1998) 8 4 (50.0) 2 (25.0) 2 (25.0) NR NR
Voormolen et al. (1995) 3 1 (33.3) 1 (33.3) 1 (33.3) NR NR
Fekete et al. (1994) 39 7 (17.9) 22 (56.4) 10 (25.6) Mean 46 months (range 18–77)a
Fogel et al. (1985) 2 1 (50.0) 0 1 (50.0) 84 months 21 months
Total 675 252 198 239

ESCC esophageal squamous cell carcinoma, IQR interquartile range, LC lung cancer, LSPT lung second primary tumor, NR not reported, sd standard deviation

aTime interval between the diagnosis of ESCC and the diagnosis of LC